Nanalyze

IPOs are back, it seems. Caris Life Sciences is planning to go public under the ticker CAI, raising over $400 million dollars at a valuation of $5 billion. Caris claims they're an AI company, but are they really using their big data to its fullest potential? In this video, we'll compare Caris to a company we've analyzed previously: Tempus AI (TEM) and see how they differ. Spoiler alert: one actually seems to be using AI, while the other isn't. Stay informed with our free disruptive technology investing newsletter, Nanalyze Weekly. Sign up now at https://www.nanalyze.com/nanalyze-weekly/ [https://www.nanalyze.com/nanalyze-weekly/]. This episode is pulled from a YouTube presentation. View the original presentation at https://youtu.be/0Y7Tm9-WhTU. [https://youtu.be/0Y7Tm9-WhTU]

If we could only hold three funds in our portfolio, which would they be? For starters, we'd look for passive funds, since 95% of active managers can't outperform a benchmark over the long term. Next, we'd look for funds with the lowest expense ratios, since that's the strongest indicator of outperformance according to Morningstar. Finally, we'd decide on our allocation. How much do we want in U.S. stocks? International stocks? Bonds? If you want to see what we came up with, you'll have to watch the video! Stay informed with our free disruptive technology investing newsletter, Nanalyze Weekly. Sign up now at https://www.nanalyze.com/nanalyze-weekly/ [https://www.nanalyze.com/nanalyze-weekly/]. This episode is pulled from a YouTube presentation. View the original presentation at https://youtu.be/wfjFuxtdkao. [https://youtu.be/wfjFuxtdkao]

Many people ask us if dividends matter. Aren't buybacks better? They're more tax efficient, after all. Well, the question is quite nuanced and blanket statements don't answer it. Today, we'll prove that dividends do matter. In fact, a company with a consistent track record of increasing dividends might just outperform the market over the long run. We have the numbers to prove it. Stay informed with our free disruptive technology investing newsletter, Nanalyze Weekly. Sign up now at https://www.nanalyze.com/nanalyze-weekly/ [https://www.nanalyze.com/nanalyze-weekly/]. This episode is pulled from a YouTube presentation. View the original presentation at https://youtu.be/JBht4ZxHRjg. [https://youtu.be/JBht4ZxHRjg]

Stablecoins are a type of cryptocurrency that actually has an intrinsic value. That's because they're pegged to the U.S. dollar - generally. You give the issuer a dollar, and you get a stablecoin. But, what's the point of that? If a stablecoin is backed by the dollar, why not just use dollars? It's because stablecoins make it easier to transact on the blockchain. And it turns out to be a pretty lucrative business, similar to an insurance company. Today's video will teach you all about stablecoins, their purpose, and what to watch out for. Stay informed with our free disruptive technology investing newsletter, Nanalyze Weekly. Sign up now at https://www.nanalyze.com/nanalyze-weekly/ [https://www.nanalyze.com/nanalyze-weekly/]. This episode is pulled from a YouTube presentation. View the original presentation at https://youtu.be/-wlbqdMm_eA. [https://youtu.be/-wlbqdMm_eA]

Our subscribers have requested that we check out Coherent stock. Since they pay our bills, we happily obliged. In today's video, we'll show you how we go about analyzing a tech stock in 5 easy steps - even if we don't know anything about the company. We'll investigate Coherent's business model, what they do, what their financials look like, and see if they'd be a candidate for a potential investment. Stay informed with our free disruptive technology investing newsletter, Nanalyze Weekly. Sign up now at https://www.nanalyze.com/nanalyze-weekly/ [https://www.nanalyze.com/nanalyze-weekly/]. This episode is pulled from a YouTube presentation. View the original presentation at https://youtu.be/TnFl6orF00s [https://youtu.be/TnFl6orF00s].